BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34625577)

  • 21. Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors.
    Miyamoto D; Miyamoto M; Takahashi A; Yomogita Y; Higashi H; Kondo S; Hatakeyama M
    Oncogene; 2008 Jun; 27(25):3508-15. PubMed ID: 18223690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells.
    Goetz B; An W; Mohapatra B; Zutshi N; Iseka F; Storck MD; Meza J; Sheinin Y; Band V; Band H
    Oncotarget; 2016 Aug; 7(32):51107-51123. PubMed ID: 27276677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia.
    Tartaglia M; Martinelli S; Cazzaniga G; Cordeddu V; Iavarone I; Spinelli M; Palmi C; Carta C; Pession A; Aricò M; Masera G; Basso G; Sorcini M; Gelb BD; Biondi A
    Blood; 2004 Jul; 104(2):307-13. PubMed ID: 14982869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TCR signaling thresholds regulating T cell development and activation are dependent upon SHP-1.
    Johnson KG; LeRoy FG; Borysiewicz LK; Matthews RJ
    J Immunol; 1999 Apr; 162(7):3802-13. PubMed ID: 10201897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SHP-2 Phosphatase Prevents Colonic Inflammation by Controlling Secretory Cell Differentiation and Maintaining Host-Microbiota Homeostasis.
    Coulombe G; Langlois A; De Palma G; Langlois MJ; McCarville JL; Gagné-Sanfaçon J; Perreault N; Feng GS; Bercik P; Boudreau F; Verdu EF; Rivard N
    J Cell Physiol; 2016 Nov; 231(11):2529-40. PubMed ID: 27100271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noonan syndrome/leukemia-associated gain-of-function mutations in SHP-2 phosphatase (PTPN11) enhance cell migration and angiogenesis.
    Wang S; Yu WM; Zhang W; McCrae KR; Neel BG; Qu CK
    J Biol Chem; 2009 Jan; 284(2):913-20. PubMed ID: 19008228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic data from NSCLC tumors reveals correlation between SHP-2 activity and PD-L1 expression and suggests synergy in combining SHP-2 and PD-1/PD-L1 inhibitors.
    Toral KJ; Wuenschel MA; Black EP
    PLoS One; 2021; 16(8):e0256416. PubMed ID: 34437586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein tyrosine phosphatase expression profile of rheumatoid arthritis fibroblast-like synoviocytes: a novel role of SH2 domain-containing phosphatase 2 as a modulator of invasion and survival.
    Stanford SM; Maestre MF; Campbell AM; Bartok B; Kiosses WB; Boyle DL; Arnett HA; Mustelin T; Firestein GS; Bottini N
    Arthritis Rheum; 2013 May; 65(5):1171-80. PubMed ID: 23335101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of SHP-2 gene transduced bone marrow mesenchymal stem cells to promote osteogenic differentiation and bone defect repair in rat.
    Fan D; Liu S; Jiang S; Li Z; Mo X; Ruan H; Zou GM; Fan C
    J Biomed Mater Res A; 2016 Aug; 104(8):1871-81. PubMed ID: 26999642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD45 regulates tyrosine phosphorylation of CD22 and its association with the protein tyrosine phosphatase SHP-1.
    Greer SF; Justement LB
    J Immunol; 1999 May; 162(9):5278-86. PubMed ID: 10228003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conditional deletion of Shp2 tyrosine phosphatase in thymocytes suppresses both pre-TCR and TCR signals.
    Nguyen TV; Ke Y; Zhang EE; Feng GS
    J Immunol; 2006 Nov; 177(9):5990-6. PubMed ID: 17056523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor.
    Chan RJ; Leedy MB; Munugalavadla V; Voorhorst CS; Li Y; Yu M; Kapur R
    Blood; 2005 May; 105(9):3737-42. PubMed ID: 15644411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation.
    Dustin LB; Plas DR; Wong J; Hu YT; Soto C; Chan AC; Thomas ML
    J Immunol; 1999 Mar; 162(5):2717-24. PubMed ID: 10072516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells.
    Xu D; Liu X; Yu WM; Meyerson HJ; Guo C; Gerson SL; Qu CK
    J Exp Med; 2011 Sep; 208(10):1977-88. PubMed ID: 21930766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tyrosine phosphatase SHP-2 binding to CTLA-4: absence of direct YVKM/YFIP motif recognition.
    Schneider H; Rudd CE
    Biochem Biophys Res Commun; 2000 Mar; 269(1):279-83. PubMed ID: 10694513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of SOV-induced phosphatase inhibition and expression of protein tyrosine phosphatases in rat corneal endothelial cells.
    Chen WL; Harris DL; Joyce NC
    Exp Eye Res; 2005 Nov; 81(5):570-80. PubMed ID: 15950220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epithelial tyrosine phosphatase SHP-2 protects against intestinal inflammation in mice.
    Coulombe G; Leblanc C; Cagnol S; Maloum F; Lemieux E; Perreault N; Feng GS; Boudreau F; Rivard N
    Mol Cell Biol; 2013 Jun; 33(11):2275-84. PubMed ID: 23530062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SHP-2 phosphatase contributes to KRAS-driven intestinal oncogenesis but prevents colitis-associated cancer development.
    Gagné-Sansfaçon J; Coulombe G; Langlois MJ; Langlois A; Paquet M; Carrier J; Feng GS; Qu CK; Rivard N
    Oncotarget; 2016 Oct; 7(40):65676-65695. PubMed ID: 27582544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells.
    Kim H; Hawley TS; Hawley RG; Baumann H
    Mol Cell Biol; 1998 Mar; 18(3):1525-33. PubMed ID: 9488469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tyrosine phosphatase SHP-1 influences thymocyte selection by setting TCR signaling thresholds.
    Carter JD; Neel BG; Lorenz U
    Int Immunol; 1999 Dec; 11(12):1999-2014. PubMed ID: 10590266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.